Condition
Locally Advanced Squamous Non-Small Cell Lung Cancer
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Withdrawn1
Not Yet Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT06279754Phase 2Not Yet RecruitingPrimary
Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy
NCT02941601Phase 2WithdrawnPrimary
A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Showing all 2 trials